Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

about

Applications of Cucurbit[n ]urils (n =7 or 8) in Pharmaceutical Sciences and Complexation of Biomolecules

P2860

Q57617975-13806033-B7FE-411B-AF9D-41CB828649A4

P2860

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

Item

http://www.wikidata.org/entity/Q38704930

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

@en

type

Item

label

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

@en

prefLabel

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

@en

P1476

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

@en

P2093

Binrui Yang

http://www.w3.org/2001/XMLSchema#string

Chunming Wang

http://www.w3.org/2001/XMLSchema#string

David Bardelang

http://www.w3.org/2001/XMLSchema#string

Linmin Chen

http://www.w3.org/2001/XMLSchema#string

Ruibing Wang

http://www.w3.org/2001/XMLSchema#string

Simon M Y Lee

http://www.w3.org/2001/XMLSchema#string

P2860

A pillararene-based ternary drug-delivery system with photocontrolled anticancer drug release.

Complexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy.

The cucurbit[n]uril family: prime components for self-sorting systems.

The ex vivo neurotoxic, myotoxic and cardiotoxic activity of cucurbituril-based macrocyclic drug delivery vehicles.

Fasudil Stimulates Neurite Outgrowth and Promotes Differentiation in C17.2 Neural Stem Cells by Modulating Notch Signalling but not Autophagy.

Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening.

Rho kinase, a promising drug target for neurological disorders.

Supramolecular Inhibition of Neurodegeneration by a Synthetic Receptor

Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection

A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II

P304

4336-4343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7OB00547D

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hang Yin

P577

2017-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28470298

http://www.w3.org/2001/XMLSchema#string

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

about

P2860

P2860

Fluorescence enhancement and pKa shift of a rho kinase inhibitor by a synthetic receptor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698